Deletion of the PER3 gene on chromosome 1p36 in recurrent ER-positive breast cancer

Journal of Clinical Oncology

Volumn 28, Issue 23, 2010, Pages 3770-3778

  Climent, Joan ^a   Perez Losada, Jesus ^a   Quigley, David A ^a   Kim, Il Jin ^a   Delrosario, Reyno ^a   Jen, Kuang Yu ^a   Bosch, Ana ^a   Lluch, Ana ^a   Mao, Jian Hua ^a   Balmain, Allan ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; MESSENGER RNA; TAMOXIFEN; CIRCADIAN RHYTHM SIGNALING PROTEIN; PER3 PROTEIN, HUMAN;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CANCER RECURRENCE; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CHROMOSOME 1P; CIRCADIAN RHYTHM; FEMALE; GENE; GENE ACTIVATION; GENE DELETION; GENE EXPRESSION; GENE LOCUS; GENE LOSS; GENETIC VARIABILITY; HUMAN; HUMAN TISSUE; LYMPH NODE; MALE; MICROARRAY ANALYSIS; MOUSE; MUTATIONAL ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; OVERALL SURVIVAL; PER3 GENE; PRIORITY JOURNAL; PROGNOSIS; ANIMAL; BREAST TUMOR; CHROMOSOME 1; DISEASE MODEL; GENE DOSAGE; GENETIC PREDISPOSITION; GENETICS; METABOLISM; SURVIVAL; TUMOR RECURRENCE;

ANIMALS; BREAST NEOPLASMS; CHROMOSOMES, HUMAN, PAIR 1; DISEASE MODELS, ANIMAL; FEMALE; GENE DOSAGE; GENE EXPRESSION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MICE; NEOPLASM RECURRENCE, LOCAL; PERIOD CIRCADIAN PROTEINS; PROGNOSIS; RECEPTORS, ESTROGEN; SEQUENCE DELETION; SURVIVAL ANALYSIS;

EID: 77957268473     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2009.27.0215     Document Type: Article

References (46)

1. Tsukamoto K, Ito N, Yoshimoto M, et al: Allelic loss on chromosome 1p is associated with progression and lymph node metastasis of primary breast carcinoma. Cancer 82:317-322, 1998 (Pubitemid 28060248)
2. Ragnarsson G, Eiriksdottir G, Johannsdottir JT, et al: Loss of heterozygosity at chromosome 1p in different solid human tumours: Association with survival. Br J Cancer 79:1468-1474, 1999 (Pubitemid 29116806)
3. Han W, Han MR, Kang JJ, et al: Genomic alterations identified by array comparative genomic hybridization as prognostic markers in tamoxifen-treated estrogen receptor-positive breast cancer. BMC Cancer 6:92, 2006
4. Borg A, Zhang QX, Olsson H, et al: Chromosome 1 alterations in breast cancer: Allelic loss on 1p and 1q is related to lymphogenic metastases and poor prognosis. Genes Chromosomes Cancer 5:311-320, 1992 (Pubitemid 23011200)
5. Bagchi A, Papazoglu C, Wu Y, et al: CHD5 is a tumor suppressor at human 1p36. Cell 128:459-475, 2007 (Pubitemid 46198889)
6. Schlisio S, Kenchappa RS, Vredeveld LC, et al: The kinesin KIF1Bbeta acts downstream from EglN3 to induce apoptosis and is a potential 1p36 tumor suppressor. Genes Dev 22:884-893, 2008 (Pubitemid 351482842)
7. Takumi T, Taguchi K, Miyake S, et al: A light-independent oscillatory gene mPer3 in mouse SCN and OVLT. EMBO J 17:4753-4759, 1998 (Pubitemid 28377175)
8. Tei H, Okamura H, Shigeyoshi Y, et al: Circadian oscillation of a mammalian homologue of the Drosophila period gene. Nature 389:512-516, 1997 (Pubitemid 27435329)
9. Xu Y, Toh KL, Jones CR, et al: Modeling of a human circadian mutation yields insights into clock regulation by PER2. Cell 128:59-70, 2007 (Pubitemid 46048889)
10. Chen ST, Choo KB, Hou MF, et al: Deregulated expression of the PER1, PER2 and PER3 genes in breast cancers. Carcinogenesis 26:1241-1246, 2005
11. Hunt T, Sassone-Corsi P: Riding tandem: Circadian clocks and the cell cycle. Cell 129:461-464, 2007 (Pubitemid 46660976)
12. Gery S, Komatsu N, Baldjyan L, et al: The circadian gene per1 plays an important role in cell growth and DNA damage control in human cancer cells. Mol Cell 22:375-382, 2006
13. Shearman LP, Jin X, Lee C, et al: Targeted disruption of the mPer3 gene: Subtle effects on circadian clock function. Mol Cell Biol 20:6269-6275, 2000 (Pubitemid 30650213)
14. Yamamoto T, Nakahata Y, Soma H, et al: Transcriptional oscillation of canonical clock genes in mouse peripheral tissues. BMC Mol Biol 5:18, 2004
15. Archer SN, Viola AU, Kyriakopoulou V, et al: Inter-individual differences in habitual sleep timing and entrained phase of endogenous circadian rhythms of BMAL1, PER2 and PER3 mRNA in human leukocytes. Sleep 31:608-617, 2008 (Pubitemid 351694249)
16. Hida A, Kusanagi H, Satoh K, et al: Expression profiles of PERIOD1, 2, and 3 in peripheral blood mononuclear cells from older subjects. Life Sci 84:33-37, 2009
17. Gery S, Koeffler HP: The role of circadian regulation in cancer. Cold Spring Harb Symp Quant Biol 72:459-464, 2007
18. Gery S, Virk RK, Chumakov K, et al: The clock gene Per2 links the circadian system to the estrogen receptor. Oncogene 26:7916-7920, 2007 (Pubitemid 350262755)
19. Zhu Y, Brown HN, Zhang Y, et al: Period3 structural variation: A circadian biomarker associated with breast cancer in young women. Cancer Epidemiol Biomarkers Prev 14:268-270, 2005 (Pubitemid 40165313)
20. Megdal SP, Kroenke CH, Laden F, et al: Night work and breast cancer risk: A systematic review and meta-analysis. Eur J Cancer 41:2023-2032, 2005 (Pubitemid 41557687)
21. Schernhammer ES, Laden F, Speizer FE, et al: Rotating night shifts and risk of breast cancer in women participating in the Nurses' Health Study. J Natl Cancer Inst 93:1563-1568, 2001 (Pubitemid 32998486)
22. Climent J, Dimitrow P, Fridlyand J, et al: Deletion of chromosome 11q predicts response to anthracycline-based chemotherapy in early breast cancer. Cancer Res 67:818-826, 2007 (Pubitemid 46192223)
23. van de Vijver MJ, He YD, van't Veer LJ, et al: A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 347:1999-2009, 2002
24. Chin K, DeVries S, Fridlyand J, et al: Genomic and transcriptional aberrations linked to breast cancer pathophysiologies. Cancer Cell 10:529-541, 2006 (Pubitemid 44854748)
25. Muller WJ, Sinn E, Pattengale PK, et al: Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene. Cell 54:105-115, 1988
26. Benjamini Y, Drai D, Elmer G, et al: Controlling the false discovery rate in behavior genetics research. Behav Brain Res 125:279-284, 2001 (Pubitemid 33000466)
27. Rubio-Moscardo F, Climent J, Siebert R, et al: Mantle-cell lymphoma genotypes identified with CGH to BAC microarrays define a leukemic sub-group of disease and predict patient outcome. Blood 105:4445-4454, 2005 (Pubitemid 40720793)
28. Bièche I, Champème MH, Matifas F, et al: Two distinct regions involved in 1p deletion in human primary breast cancer. Cancer Res 53:1990-1994, 1993
29. Matsuzaki M, Nagase S, Abe T, et al: Detailed deletion mapping on chromosome 1p32-p36 in human colorectal cancer: Identification of three distinct regions of common allelic loss. Int J Oncol 13:1229-1233, 1998 (Pubitemid 28551549)
30. Ebisawa T, Uchiyama M, Kajimura N, et al: Association of structural polymorphisms in the human period3 gene with delayed sleep phase syndrome. EMBO Rep 2:342-346, 2001 (Pubitemid 32401531)
31. Archer SN, Robilliard DL, Skene DJ, et al: A length polymorphism in the circadian clock gene Per3 is linked to delayed sleep phase syndrome and extreme diurnal preference. Sleep 26:413-415, 2003 (Pubitemid 39610658)
32. Arendt J: Managing jet lag: Some of the problems and possible new solutions. Sleep Med Rev 13:249-256, 2009
33. von Schantz M: Phenotypic effects of genetic variability in human clock genes on circadian and sleep parameters. J Genet 87:513-519, 2008
34. Khan SA, Rogers MA, Obando JA, et al: Estrogen receptor expression of benign breast epithelium and its association with breast cancer. Cancer Res 54:993-997, 1994
35. Yager JD, Davidson NE: Estrogen carcinogenesis in breast cancer. N Engl J Med 354:270-282, 2006
36. Sørlie T, Perou CM, Tibshirani R, et al: Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A 98:10869-10874, 2001 (Pubitemid 32878711)
37. Sorlie T, Tibshirani R, Parker J, et al: Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci U S A 100:8418-8423, 2003 (Pubitemid 36842560)
38. Medina D, Butel JS, Socher SH, et al: Mammary tumorigenesis in 7,12-dimethybenzanthracene-treated C57BL x DBA/2f F1 mice. Cancer Res 40:368-373, 1980 (Pubitemid 10140165)
39. Liu AC, Welsh DK, Ko CH, et al: Intercellular coupling confers robustness against mutations in the SCN circadian clock network. Cell 129:605-616, 2007 (Pubitemid 46660967)
40. Shearman LP, Zylka MJ, Weaver DR, et al: Two period homologs: Circadian expression and photic regulation in the suprachiasmatic nuclei. Neuron 19:1261-1269, 1997 (Pubitemid 28030545)
41. Viola AU, Archer SN, James LM, et al: PER3 polymorphism predicts sleep structure and waking performance. Curr Biol 17:613-618, 2007 (Pubitemid 46497792)
42. Groeger JA, Viola AU, Lo JC, et al: Early morning executive functioning during sleep deprivation is compromised by a PERIOD3 polymorphism. Sleep 31:1159-1167, 2008
43. Collis SJ, Boulton SJ: Emerging links between the biological clock and the DNA damage response. Chromosoma 116:331-339, 2007 (Pubitemid 46995573)
44. Yagita K, Yamaguchi S, Tamanini F, et al: Dimerization and nuclear entry of mPER proteins in mammalian cells. Genes Dev 14:1353-1363, 2000 (Pubitemid 30397079)
45. Eriguchi M, Levi F, Hisa T, et al: Chronotherapy for cancer. Biomed Pharmacother 57:92s-95s, 2003 (suppl 1)
46. Lévi F: Chronotherapeutics: The relevance of timing in cancer therapy. Cancer Causes Control 17:611-621, 2006